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OBJECTIVES The main objective of the present study was to establish whether 17-estradiol (E2) regulates
expression of cardiac adenosine triphosphate-sensitive potassium (KATP) channel.
BACKGROUND Based on our previous studies that demonstrate gender-specific differences in sarcolemmal
KATP channels, we have hypothesized that the main estrogen, E2, may regulate expression of
cardiac KATP channels.
METHODS Reverse transcription-polymerase chain reaction (RT-PCR) using primers specific for Kir6.2
and sulfonylurea receptor 2A (SUR2A) subunits was performed on total ribonucleic acid
(RNA) from rat embryonic heart-derived H9c2 cells. Immunoprecipitation and Western
blotting using anti-Kir6.2 and anti-SUR2A antibodies was done on membrane fraction of
H9c2 cells. Whole cell electrophysiology and digital epifluorescent Ca2 imaging were
performed on living H9c2 cells. All experiments were done in cells incubated 24 h with or
without 100 nM E2.
RESULTS The RT-PCR revealed higher levels of SUR2A, but not Kir6.2, messenger RNA (mRNA)
in E2-treated, relative to untreated, cells. Increase of the level of only the SUR2A subunit
could change the number of sarcolemmal KATP channels only if the Kir6.2 is in excess over
SUR2A. Indeed, RT-PCR analysis demonstrated considerably lower levels of SUR2A
mRNA compared with Kir6.2 mRNA. Significantly higher levels of both Kir6.2 and SUR2A
protein subunits were found in the membrane fraction of E2-treated cells compared with
untreated ones, and the density of current evoked by pinacidil (100 M), a KATP channel
opener, was significantly higher in E2-treated compared with untreated cells. To test the
effect of E2 on cellular response to hypoxia-reoxygenation, we have measured on-line,
intracellular concentration of Ca2 in H9c2 cells exposed to hypoxia-reoxygenation.
Intracellular Ca2 loading induced by hypoxia-reoxygenation was significantly decreased by
treatment with E2. This E2-mediated protection was inhibited by HMR 1098 (30 M), but
not by 5-hydroxydecanoate (50 M).
CONCLUSIONS In conclusion, this study has demonstrated that E2 increases levels of SUR2A subunit,
stimulates KATP channel formation and protects cardiac cells from hypoxia-
reoxygenation. (J Am Coll Cardiol 2002;40:367–74) © 2002 by the American College of
Cardiology Foundation
While the risk of heart disease in men increases constantly
with age, premenopausal women have a significantly lower
risk, which, however, increases rapidly after menopause to
levels comparable to male counterparts (1). Estrogen sub-
stitution in postmenopausal women reduces cardiovascular
mortality by 30% to 50%, suggesting that estrogens are
protective (2). In this respect, the antiatherogenic action of
estrogens on the lipid profile and arterial wall has been
well-documented (3). However, more recent studies sug-
gested that estrogens could directly target cardiomyocytes
and protect them against metabolic stress. Specifically, it has
been shown that physiologic concentration of 17-estradiol
(E2) protects ventricular cardiomyocytes against hypoxia-
reoxygenation (4). The mechanism of this protection is yet
unknown. It has been recently suggested that a gender-
specific difference in cardiac resistance to metabolic stress
might be associated with higher levels of sarcolemmal
adenosine triphosphate-sensitive potassium (KATP) chan-
nels in females compared with males (5).
It is believed that the activation of a KATP channel is an
important part of endogenous cardioprotective signaling
that promotes cellular survival under metabolic challenge
(6). In numerous studies, it has been demonstrated that
potassium channel openers, drugs that promote opening of
KATP channels, decrease infarct size, mimic ischemic pre-
conditioning and improve functional and energetic recovery
of cardiac muscle after ischemic and hypoxic insults (7).
More recently, evidence has been provided to suggest that
activation of both sarcolemmal and putative mitochondrial
KATP channels may promote cellular survival (7,8). The
structure of mitochondrial KATP channels is still unknown,
but the proteins constituting the sarcolemmal KATP channel
complex have been cloned (9–12). Sarcolemmal KATP
channels are heteromultimers composed of, at least, two
structurally distinct subunits. In heart, the pore-forming
inwardly rectifying K channel core, Kir6.2, is primarily
responsible for K permeance, whereas the regulatory sub-
unit, also known as the sulfonylurea receptor, or SUR2A,
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has been implicated in ligand-dependent channel gating
(11).
In the present study we have hypothesized that estrogens
may regulate expression of sarcolemmal KATP channels.
This hypothesis was based on our previous studies that
demonstrated: 1) more sarcolemmal KATP channels in
females than in males (5), and 2) aging-induced decrease in
number of sarcolemmal KATP channels in females (13). We
have tested the hypothesis that estrogens may be a regulator
of KATP channel expression in the heart using heart-derived
H9c2 cell line. These cells were derived from embryonic rat
hearts, and they have properties similar to neonatal and
adult cardiomyocytes (14–16). Thus, we have employed
reverse transcription-polymerase chain reaction (RT-PCR),
Western blotting analysis, patch clamp electrophysiology
and digital epifluorescent imaging to test the hypothesis that
E2 regulates expression of cardiac KATP channels.
We report that E2 regulates expression of the SUR2A
subunit which, in turn, increases the number of sarcolemmal
KATP channels and promotes cellular resistance to hypoxia-
reoxygenation.
METHODS
Heart h9C2 cells. Rat embryonic heart H9c2 cells
(ECACC, Salisbury, United Kingdom) were cultured in a
tissue flask (at 5% CO2) containing Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum
and 2 mM glutamine. For electrophysiologic and imaging
experiments, cells were plated on a 35·10 mm or 60·15 mm
culture dish, containing 12-mm or 25-mm glass coverslips.
Cells were incubated for 24 h before experimentation
without or with 100 nM E2 (Sigma, Dorset, United
Kingdom).
Measurement of ribonucleic acid (RNA) levels. Total
RNA was then isolated using a commercial kit (RNeasy,
Mini Kit, Qiagen, Hilden, Germany) according to the
manufacturers instructions. First strand complementary de-
oxyribonucleic acid (cDNA) was synthesized with random
hexanucleotides from 1 mg of total RNA using Reverse
Transcription System kit (Promega, Southampton, United
Kingdom). Polymerase chain reactions (PCRs) were done
using ReadyMix Red Tag from Sigma in a thermal cycler
Model Phoenix (Helena Biosciences, Sunderland, United
Kingdom) under the following conditions: for Kir 6.2: 94°C
for 3 min, 34 cycles (94°C for 0.5 min, 66.1°C for 0.5 min,
70°C for 1 min), final extension at 70°C for 5 min; for
SUR2A the conditions were the same as for Kir6.2 except
that the number of cycles was 49 and the annealing
temperature was 66.1°C. The primers had the following
sequences, for the 387 base-long product for rat Kir6.2:
sense, 5-ATGCGCAAGACCACCAGC-3; antisense,
5-TGGCGGGCTGTGCAGAG-3. For the 375 base-
long product for rat SUR2A: sense, 5-CTAGACGC-
CACTGTCAC-3; antisense, 5-AGAGAACGA-
GACACTTGG-3. In experiments set to determine the
concentration-dependent effect of E2 on SUR2A messenger
RNA (mRNA), the following primers were used: sense,
5-CTAGACGCCACTGTCAC-3; antisense, 5-
AGAGAACGAGACACTTGG-3. Reverse transcription
polymerase chain reaction conditions were as described
above for SUR2A mRNA, and 36 to 40 cycles were used.
The loading of RNA was checked by human
glyderaldehyde-3-phosphate dehydrogenase (GAPDH)-
primers : sense , 5 -CATCACCATCTTCCAG-
GAGCGA-3; antisense, 5-GTCTTCTGGGTG-
GCAGTGATGG-3; the size of GAPDH-product was
341 base pairs). There were no significant differences in
intensity of GAPDH-levels between experimental groups.
The nature of PCR product was confirmed by deoxyribo-
nucleic acid sequencing. The PCR product band intensities
were analyzed using the Quantiscan software.
Immunoprecipitation and Western blotting analysis.
Sheep antipeptide antibodies were raised against synthetic
peptides comprised of residues 33 to 47 in the Kir6.2
protein (ARFVSKKGNCNVAHK) and residues 311 to 32
in the SUR2A protein (CIVQRVNETQNGTNN), con-
jugated to a carrier protein, keyhole limpet hemocyanin,
and used for immunoprecipitation and Western blotting.
To obtain the membrane fraction, H9c2 cardiac cells
were homogenized in buffer I (tris[hydroxymethyl]-
aminomethane 10 mM, NaH2PO4 20 mM, ethylenediamine-
tetraacetic acid 1 mM, phenylmethyl sulfonyl fluoride
0.1 mM, pepstatin 10 g/ml, leupeptin 10 g/ml, at pH 
7.8) and incubated for 20 min (at 4°C). The osmolarity was
restored with KCl, NaCl and sucrose, and the obtained
mixture was centrifugated at 500 g. The supernatant was
diluted in buffer II (imidazole 30 mM, KCl 120 mM, NaCl
30 mM, NaH2PO4 20 mM, sucrose 250 mM, pepstatin
10 g/ml, leupeptin 10 g/ml, at pH  6.8) and centrifu-
gated at 7,000 g, pellet removed and supernatant centrifu-
gated at 30,000 g. The obtained pellet contains membrane
fraction. Ventricular tissue was snap-frozen immediately
upon extraction and ground to a powder under liquid
nitrogen. The powder was resuspended in 10 ml of tissue
buffer (20 mM Hepes, 150 mM NaCl, 1% Triton-X 100,
pH 7.5) and homogenized. Protein concentration was
determined using the method of Bradford; 10 g of the
Abbreviations and Acronyms
AU  arbitrary units
cDNA  complementary deoxyribonucleic acid
E2  17-estradiol
GAPDH  glyceraldehyde-3-phosphate dehydrogenase
KATP  adenosine triphosphate-sensitive potassium
channel
mRNA  messenger ribonucleic acid
PCR  polymerase chain reaction
RNA  ribonucleic acid
RT-PCR  reverse transcription-polymerase chain
reaction
SUR2A  sulfonylurea receptor 2A
5-HD  5-hydroxydecanoate
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epitope-specific Kir6.2 antibody or 40 g of the epitope-
specific SUR2A antibody was prebound to Protein-G
Sepharose beads and used to immunoprecipitate from 50 g
of membrane fraction protein extract. The pellets of this
precipitation were run on SDS polyacrylamide gels, for
Western analysis. Western blot probing was performed
using 1/200 and 1/300 dilutions of anti-SUR2A and anti-
Kir6.2 antibody, respectively, and detection was achieved
using Protein-G horse radish peroxydase and enhanced
chemiluminescence reagents.
Electrophysiology. Cells were superfused with Tyrode so-
lution (in mM: 136.5 NaCl, 5.4 KCl, 1.8 CaCl2, 0.53
MgCl2, 5.5 glucose, 5.5 HEPES-NaOH, pH 7.4). Pipettes
(resistance 3 to 5 M) were filled with (in mM): KCl 140,
MgCl2 1, ATP 3, HEPES-KOH 5 (pH 7.3). Recordings
were made at room temperature (22°C). During each
experiment, the membrane potential was normally held at
40 mV, and the currents evoked by a series of 400 ms
current steps (40 mV to 80 mV in 20 mV steps)
recorded directly to hard disk using an Axopatch-200B
amplifier, Digidata-1321 interface and pClamp8 software
(Axon Instruments, Inc., Forster City, California). The
capacitance compensation was adjusted to null the addi-
tional whole-cell capacitative current. The slow capacitance
component measured by this procedure was used as an
approximation of the cell surface area and allowed normal-
ization of current amplitude (i.e., current density). Currents
were low-pass filtered at 2 kHz and digitized.
Digital epifluorescent microscopy. H9c2 cells were super-
fused with Tyrode solution and loaded with the esterified
form of the Ca2-sensitive fluorescent probe Fura-2 (Fura-
2AM, dissolved in dimethyl sulfoxide plus pluronic acid;
Molecular Probes, Eugene, Oregon). Cells were imaged
using a digital epifluorescence imaging system coupled to an
inverted microscope (Image Solutions, Standish, United
Kingdom). A mercury lamp served as a source of light to
excite Fura-2AM at 340 nm and 380 nm. Fluorescence
emitted at 520 nm was captured, after crossing dichroic
mirrors, by an intensified charge-coupled device camera and
digitized using an imaging software. An estimate of the
cytosolic Ca2 concentration, as a function of Fura-2
fluorescence, was calculated according to the equation:
[Ca2]  (R  Rmin/Rmax  R) Kd
where R is the fluorescence ratio recorded from the cell,
Rmin and Rmax is the minimal and maximal fluorescence
ratio, Kd is the dissociation constant of the dye (236 nM)
and  is the ratio of minimum to maximum fluorescence at
380 nm. Hypoxia-reoxygenation was induced as follows:
single field-stimulated (30 mV, 5 ms, 0.5 Hz) cells were
perfused with Tyrode solution containing (in mM) NaCl
136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glucose 5.5,
HEPES-NaOH 5.5 (pH 7.4) at a rate of 1 ml/min. Under
these conditions the PO2 in perfusate was approximately 140
mm Hg. For hypoxia the solution was continuously bubbled
with 100% argon while the exchange of O2 between solution
in the chamber and air was prevented by nitrogen jet. The
PO2 under these conditions was approximately 20 mm Hg.
The duration of hypoxia was 10 min, followed by reoxygen-
ation with Tyrode solution for 10 min. Some experiments
were done under the presence of 30 M HMR 1098
(Aventis Pharma, Frankfurt, Germany) or 50 M
5-hydroxydecanoate (5-HD, RBI, Natick, Massachusetts).
Statistical analysis. Data are presented as mean  SEM,
with n representing the number of experiments. Mean
values obtained were compared by the paired or unpaired
Student’s t test where appropriate. Results for Kir6.2 and
SUR2A obtained with RT-PCR for each sample were
normalized taking into account GAPDH levels regardless
that they were not significantly different in tested samples.
The difference between means were assessed using t test
(paired or unpaired), by Tukey test, chi-square test or by the
two-way repeated measures analysis of variance using
SigmaStat program (Jandel Scientific, Chicago, Illinois).
A p value of  0.05 was considered statistically significant.
RESULTS
Higher levels of SUR2A mRNA, but not Kir6.2 mRNA,
in E2-treated cells. Reverse transcription polymerase
chain reaction analysis of H9c2 cells demonstrated higher
levels of SUR2A mRNA in E2-treated cells relative to
untreated ones (PCR product band intensity was 7.7  0.3
arbitrary units [AU] for untreated and 13.5  0.5 for
E2-treated cells, n  3 of each, p  0.01; Fig. 1B). In
contrast, Kir6.2 mRNA levels were similar between two
groups of cells, irrespective whether they were treated with
E2 (Fig. 1A; intensity of bands were 28.0  2.0 AU in
control and 25.9  2.1 AU in E2-treated cells, n  3 for
each, p  0.54). No differences were observed between
GAPDH levels after treatment with E2 (Fig. 1C; intensity
of bands were 6.5  0.5 AU in control and 6.0  1.0 AU
in E2-treated cells, n  3 for each, p  0.69). The effect of
E2 on SUR2A mRNA levels was concentration-dependent
(Fig. 1D; n  3 for each, p  0.001).
Kir6.2 mRNA is present in higher amounts in H9c2 cells
than SUR2A mRNA. From the same cDNA pool, differ-
ent volumes of Kir6.2 and SUR2A cDNA were taken and
subjected to PCR using the best conditions for both
reactions. The first product band for Kir6.2 was visible with
0.01 l of cDNA at 34 cycles of the PCR reaction, while
SUR2A product was visualized with 1 l of cDNA at 49
cycles. Because each cycle of the PCR reaction doubles
amount of products, there were considerably smaller
amounts of SUR2A mRNA compared with Kir6.2 mRNA
in H9c2 cells.
E2 increases the number of KATP channels in H9c2
cells. To determine whether E2 regulates the number of
Kir6.2/SUR2A channels in plasmalemma, we have immu-
noprecipitated the membrane fraction with anti-Kir6.2
antibody and “probed” the precipitate with the anti-SUR2A
antibody and vice verse. Western blotting analysis revealed
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Figure 1. Kir6.2 and sulfonylurea receptor 2A (SUR2A) messenger ribonucleic acid levels in untreated and 17-estradiol (E2)-treated H9c2 heart cells.
(A to D) Reverse transcription-polymerase chain reaction (RT-PCR) products obtained with Kir6.2-, SUR2A- and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)-specific primers from untreated and E2-treated cells. (A1 to C1) Graphs corresponding to RT-PCR products depicted in A to
D. Each bar represents mean  SEM. *p  0.05 when compared with the control.
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higher levels of both Kir6.2 and SUR2A proteins in
E2-treated cells compared with untreated ones (Kir6.2: the
band intensity was 10.8 2.7 AU for untreated and 22.5 
2.5 AU for E2-treated cells, n  4 of each, p  0.01; Fig.
2A; SUR2A: the band intensity was 11.8  1.3 AU for
untreated and 26.0  3.2 AU for E2-treated cells, n  4 of
each, p 0.006; Fig. 2B). In both untreated and E2-treated
cells, pinacidil (100 M), a opener of KATP channels,
induced the outward membrane current. The pinacidil-
sensitive component was significantly larger in E2-treated
than untreated cells (current density at 80 mV was 2.1 0.2
pA/pF in control and 3.2  0.3 pA/pF in E2-treated cells,
p  0.01, n  7 for each).
E2-treated cells are more resistant to hypoxia-
reoxygenation injury then untreated cells. To test the
effect of E2 on cellular response to hypoxia-reoxygenation,
we have measured on-line, intracellular concentration of
Ca2 in H9c2 cells exposed to hypoxia-reoxygenation.
Figure 3A depicts the typical experiment. At rest, untreated
and E2-treated cells had similar levels of cytosolic Ca2
(untreated: 56  5 nM, n  7; E2-treated: 50  5 nM, p
 0.46, n  9; Fig. 3A). In untreated cells, hypoxia-
reoxygenation induced significant intracellular Ca2 loading
(154  7 nM, p  0.001 when compared with the control;
n  7, Fig. 3A). In contrast, cells treated with E2 had a
significantly lower increase of intracellular Ca2 during
hypoxia-reoxygenation than untreated ones (E2-treated: 82
 6 nM, n  9, p  0.004 when compared with untreated
cells, Fig. 3A). There was a statistically significant interac-
tion between E2-treatment and cellular response to the
hypoxia-reoxygenation (p  0.011). In untreated group of
cells, 22% did not respond with Ca2 loading to hypoxia-
reoxygenation challenge, while, in the E2-treated cell group,
this number was significantly higher, 68% (Fig. 3B, p  
Figure 2. Adenosine triphosphate-sensitive potassium channel levels in plasma membrane of untreated and 17-estradiol (E2)-treated H9c2 cells. Western
blot with anti-Kir6.2 (A) and anti-sulfonylurea receptor 2A (SUR2A) (B) of anti-SUR2A (A) and anti-Kir6.2 (B) immunoprecipitate pellets from
membrane fractions from untreated and E2-treated H9c2 cells. (A1 and B1) Graphs correspond to A and B. Each bar represents mean SEM. *p 0.05.
IP  immunoprecipitate.
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0.001); HMR 1098 (30 M), a sarcolemmal KATP channel
blocker, partially restored sensitivity to hypoxia/
reoxygenation in the E2-treated group (Fig. 3B, 41% of
cells responded with Ca2 loading, which was not signifi-
cantly different compared with untreated cells, p  0.134).
In contrast, 5-HD (50 M), an antagonist of mitochondrial
Figure 3. Hypoxia/reoxygenation (H/R)-induced Ca2 loading in untreated and 17-estradiol (E2)-treated H9c2 cells in the absence and presence of
HMR 1098 (3 M) and 5-hydroxydecanoate (5-HD) (50 M), sarcolemmal and mitochondrial Adenosine triphosphate-sensitive potassium channel
blockers, respectively. (A) Epifluorescent digital images of untreated and E2-treated Fura-2 loaded cells before (left panel) and after H/R (right panel).
White bar corresponds to 30 m. Graphs are time courses of intracellular concentration of Ca2 and correspond to experiments depicted on the left. Each
line on graphs represents a single cell from the corresponding image field. (B) Percentage of cells that responded (defined as 50% increase in resting Ca2
with the time-course pattern of Ca2 increase as depicted in A)/did not respond to H/R with Ca2 loading under control conditions (untreated) and 24 h
treatment with E2 in the absence (E2) and presence of HMR 1098 (E2  HMR 1098) and 5-HD (E2  5-HD), n  29 to 45.
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KATP channels, did not inhibit protection afforded by E2
treatment (Fig. 3B, p  0.001 when compared with the
control).
DISCUSSION
This study demonstrates that E2 stimulates the expression
of SUR2 subunit in the heart-derived cell line, leading to an
increase in the number of sarcolemmal KATP channels and
increased resistance to hypoxia-reoxygenation. This is the
first report of a hormone-regulating expression of cardiac
KATP channels, ion channels that transduce metabolic status
of a cell into membrane excitability.
The effect of E2 on Kir6.2 and SUR2A mRNA levels. In
this study semiquantitative RT-PCR revealed that treat-
ment with E2 increases the levels of SUR2A mRNA, but
not Kir6.2 mRNA. The higher levels of SUR2A mRNA,
but not Kir6.2 mRNA, in E2-treated cells compared with
untreated ones resembles our results previously obtained on
female and male adult cardiomyocytes, that is, higher levels
of SUR2A mRNA in female compared with male cardio-
myocytes (5). The concentration-dependent nature of E2
action shows that this effect is genuine and mediated
through a saturable binding site, which is in accord with the
receptor-mediated effect of a hormone. Considering that
Kir6.2 and SUR2A subunits form the KATP channel in 1:1
ratio (17), higher levels of only one subunit does not
necessarily mean that more KATP channels will be formed.
In adult cardiomyocytes, we have previously demonstrated
that the Kir6.2 subunit is in excess over the SUR2A subunit
(5). The biological consequence of this disproportion be-
tween Kir6.2 and SUR2A levels is that the number of
sarcolemmal KATP channels is solely controlled by the levels
of SUR2A (5). In this study, similarly as in adult cardio-
myocytes (5), RT-PCR revealed higher amounts of Kir6.2
mRNA than SUR2A mRNA, suggesting that fluctuation of
SUR2A levels regulates the number of KATP channels in
H9c2 cells and that an increase in SUR2A mRNA may be
sufficient to increase the levels of the channel proteins.
The effect of E2 on number of KATP channels in
plasmalemma. In sarcolemma, Kir6.2 and SUR2A physi-
cally associate to form KATP channels (17). To secure
measuring of only those subunits forming the channel, we
have immunoprecipitated cardiac membrane fraction with
anti-Kir6.2 antibody and then “probed” with anti-SUR2A
antibody and otherwise around. Using this approach to
measure only subunits coprecipitated with each other, we
have excluded subunits that are present in the cell but do not
form the channel. Both Kir6.2 and SUR2A subunits are
found in much higher levels in membrane fraction from
E2-treated than untreated cells, thus providing direct evi-
dence that E2 increases density of plasma membrane KATP
channels in H9c2 cells. This conclusion was further sup-
ported by the whole cell electrophysiology. Because in intact
cardiomyocytes KATP channels are normally closed, chan-
nels were activated by pinacidil, an established opener of
KATP channels (18,19). Our findings that the magnitude of
the response to pinacidil followed the pattern of Kir6.2 and
SUR2A membrane levels is in accord with the notion that
E2 increases cardiac KATP channel density. The apparent
discrepancy between the results obtained with RT-PCR
methodology (differences only in SUR2A levels) and West-
ern blotting (differences in both Kir6.2 and SUR2A levels)
could be explained by the fact that RT-PCR measured
levels of total SUR2A and Kir6.2 mRNA, while Western
blot selectively measured levels of those SUR2A and Kir6.2
subunits that are physically associated to form the channels.
These findings further support the notion that the SUR2A
subunit controls the number of functional channel proteins
in cardiac cells and that E2 controls the number of sar-
colemmal KATP channels by regulating expression of the
SUR2A subunit.
The effect of E2 on resistance to hypoxia-reoxygenation.
The consequence of E2-mediated regulation of KATP chan-
nel expression has yet to be fully understood. It has been
previously shown that physiologic replacement of estradiol
protects the myocardium after global ischemia in the ovari-
ectomized animals (20). Also, we have demonstrated that
cardiomyocytes from females are more resistant to metabolic
stress compared with those in males (5) and that E2 directly
protects adult cardiomyocytes against chemical hypoxia/
reoxygenation (4). It has been also reported that E2 treat-
ment promotes survival of H9c2 cells exposed to glucose-
deprived/hypoxic condition (16). In this study we have
measured intracellular concentration of Ca2 as a parameter
that reflects the metabolic condition of a cardiac cell
(4,5,18). As expected, hypoxia-reoxygenation induced intra-
cellular Ca2 loading in H9c2 cells, indicating that these
cells are vulnerable to such an insult. The fact that treatment
with E2 protected these cells against hypoxia/
reoxygenation-induced Ca2 loading are compatible with
the notion that E2 possess direct cardioprotective properties
(4) associated with the E2 property to regulate expression of
KATP channels. Inhibition of the E2-mediated protection
with HMR 1098, a selective sarcolemmal KATP channel
blocker (21), directly associates the beneficial effect of E2
with upregulation of sarcolemmal KATP channels. The
cardioprotective role of sarcolemmal KATP channels has
been contested in the last few years (22), but more recent
reports reaffirm the idea that opening of sarcolemmal KATP
channels protects against metabolic stress (23–25). Our
finding that the predominant blocker of mitochondrial
KATP channels, 5-HD (22), did not inhibit the protective
effect of E2, excludes the possibility that these channels
were actively involved in protection afforded by E2. The
observed E2-mediated upregulation of sarcolemmal KATP
channels and increased resistance to metabolic stress is in
agreement with previous studies showing positive correla-
tion between plasma levels of estrogens and number of
sarcolemmal KATP channels and the cardiomyocyte’s resis-
tance to metabolic insult (5,13). Therefore, it seems that one
of the consequences of E2 action on cardiomyocytes, either
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adult or embryonic, is more KATP channels expressed on
plasmalemma and increased resistance towards metabolic
stress.
Study limitations. The main limitation of the study might
be that it was done on embryonic heart-derived cell line and
not on adult cardiomyocytes. However, bearing in mind that
properties of H9c2 cells are similar to those in adult
cardiomyocytes (13–15), it is likely that the findings from
this study are of relevance for adult cardiomyocytes as well.
Conclusions. In conclusion, this study has demonstrated
that E2 increases levels of the SUR2A subunit, stimulates
KATP channel formation and protects cardiac cells from
hypoxia-reoxygenation. The obtained results could provide
a basis for developing therapeutic strategies against ischemic
heart disease centered around KATP channels.
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